Vascular Grafts Market Research and Forecast Report 2023-2028

1. Global Vascular Grafts Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Vascular Grafts Market Research Report: The latest report by IMARC, titled “Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " the global vascular grafts market reached a value of US$ 1.8 Billion in 2022. Vascular grafts are medical devices used to replace or repair damaged blood vessels. They are made from synthetic materials or harvested from a patient's tissue, such as veins or arteries. They are used in various surgical procedures, including coronary artery bypass surgery, peripheral artery bypass surgery, and hemodialysis access. Several types of vascular grafts are available, including synthetic, biological, and hybrid grafts. Synthetic grafts, such as polytetrafluoroethylene (PTFE) and expanded polytetrafluoroethylene (ePTFE), are commonly used due to their durability and resistance to infection. Biological grafts, such as bovine or porcine-derived grafts, are also available that offer a more natural structure better suited to certain procedures. Hybrid grafts, which combine synthetic and biological materials, are sometimes used. Vascular grafts restore blood flow to damaged or diseased blood vessels. They can be used to bypass blockages or narrowings in arteries to provide access for hemodialysis or to repair damaged vessels caused by trauma or disease. The success of a vascular graft procedure depends on several factors, including the graft type used, the size and location of the damaged vessel, and the patient's overall health. Vascular grafts can be customized to fit the patient's specific needs, with options like synthetic or biological materials, different sizes and shapes, and the ability to combine materials for hybrid grafts. Request Free Sample Report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

4. Report Description and Highlights Report Description Global Vascular Grafts Market Trends: The global market is primarily driven by the growing prevalence of peripheral arterial disease, aneurysms, and end- stage renal disease. As the population ages and lifestyles become more sedentary, the incidences of these conditions increases, leading to a greater need for vascular grafts to restore blood flow and prevent serious health complications. In line with this, continuous technological advances are significantly contributing to the market growth. Furthermore, rising healthcare expenditures are positively influencing the market. Apart from this, the development of advanced medical devices, such as imaging technologies, artificial intelligence, and robotics, is catalyzing the product demand. Moreover, the escalating awareness of the benefits offered by vascular grafts among patients, physicians, and other healthcare professionals is propelling the market. Besides, the rising number of dialysis procedures and the escalating chronic kidney disease (CKD) cases globally are favoring the market. The widespread availability of reimbursement policies is strengthening the market worldwide. Additionally, extensive utilization of prosthetic grafts, such as electrospun polyurethane vascular grafts for complex vascular trauma as it lowers the risks of neointimal formation, is expected to provide a boost to the market. On account of the factors above, the market is anticipated to reach a value of US$ 2.6 Billion by 2028, exhibiting a CAGR of 6.1% during 2023-2028. Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

5. Report Description and Highlights Report Description Market Summary: Breakup by Product: • Endovascular Stent Grafts • Hemodialysis Access Grafts • Coronary Artery By-Pass Grafts • Vascular Grafts for Aorta Disease • Peripheral Vascular Grafts Breakup by Raw Material: • Polytetrafluoroethylene (PTFE) • Polyester • Polyurethane • Biosynthetic Breakup by Application: • Cardiac Aneurysm • Kidney Failure • Vascular Occlusion

6. Report Description and Highlights Report Description • Coronary Artery Disease Breakup by End User: • Hospitals • Ambulatory Surgical Centers (ASCs) Breakup by Region: • North America • United States • Canada • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany

7. Report Description and Highlights Report Description • France • United Kingdom • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

8. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • • • Abbott Laboratories B. Braun SE (B. Braun Holding GmbH & Co. KG) Becton Dickinson and Company Cook Group Incorporated Cordis CryoLife Inc. Getinge AB Heat Medical Europe BV LeMaitre Vascular Medtronic plc Terumo Corporation W. L. Gore & Associates Inc. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/vascular-grafts-market

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com